SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 36 filers reported holding SCPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,000 | +36.8% | 3,616 | +91.1% | 0.00% | – |
| Q2 2023 | $19,000 | – | 1,892 | +15666.7% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 12 | -99.4% | 0.00% | – |
| Q2 2022 | $10,000 | – | 2,056 | +3571.4% | 0.00% | – |
| Q1 2022 | $0 | – | 56 | -23.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 73 | -7.6% | 0.00% | – |
| Q3 2021 | $1,000 | -80.0% | 79 | -91.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 874 | +3.9% | 0.00% | – |
| Q1 2021 | $6,000 | +200.0% | 841 | +80.5% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 466 | +298.3% | 0.00% | – |
| Q1 2020 | $1,000 | -98.3% | 117 | -98.9% | 0.00% | – |
| Q3 2018 | $60,000 | -46.9% | 10,227 | -49.0% | 0.00% | – |
| Q2 2018 | $113,000 | – | 20,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,857,143 | $35,429,000 | 2.71% |
| Orbimed Advisors | 3,409,865 | $42,282,000 | 0.52% |
| AWM Investment Company, Inc. | 213,317 | $2,645,000 | 0.51% |
| DAFNA Capital Management LLC | 55,844 | $692,000 | 0.34% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 40,373 | $501,000 | 0.07% |
| Alyeska Investment Group, L.P. | 223,438 | $2,771,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,330 | $302,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 69,500 | $862,000 | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 36,206 | $449,000 | 0.00% |
| PEDDOCK CAPITAL ADVISORS, LLC | 100 | $1,000 | 0.00% |